• Strong cost and market leadership in specific API’s
  • Diversified manufacturing capabilities in different types of API’s (SSP’s, carbapenams, Cephalosporin’s, synthetic products etc).
  • Our API facilities are approved by USFDA, EDQM, WHO.
  • API technology development and manufacturing capabilities.
  • Strong R&D base for new molecules development activities.
  • State of art API facilities with latest technological capabilities for execution.
  • Strong quality compliance systems to ensure consistent supply of quality API’s
  • Capabilities of sterile API manufacturing.